New PTSD drug shows promise in major trial
Symptom relief
Recruiting now
This study tests a new drug called TSND-201 to see if it can safely reduce PTSD symptoms in adults. About 300 people will receive one of two doses of the drug or a placebo once a week for 4 weeks, then be followed for 8 more weeks. The goal is to measure changes in PTSD severity …
Phase: PHASE3 • Sponsor: Transcend Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 08:09 UTC